# Cogent Biosciences, Inc.: Form SCHEDULE 13D/A, filed Mar 31, 2026

- Company: [Cogent Biosciences, Inc.](/companies/cogt.md) (CIK 1622229)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-31
- Accepted by EDGAR: Mar 31, 2026, 21:30 ET
- Period: not reported
- Accession: 0001104659-26-038056
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1622229/000110465926038056/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1622229/000110465926038056/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1622229/000110465926038056/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Mar 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-038056. Last ingested by Listed: Nov 5, 2026, 18:48 ET. No prices; not investment advice.